FXR1 regulates vascular smooth muscle cell cytoskeleton, VSMC contractility, and blood pressure by multiple mechanisms.
暂无分享,去创建一个
D. Haines | M. Autieri | Kyle J. Preston | S. Kelemen | Amanda St. Paul | Amanda M. Peluzzo | Rachael Okune | Satoru Eguchi | Cali B. Corbett
[1] K. Rottner,et al. WAVE regulatory complex , 2021, Current Biology.
[2] S. Eguchi,et al. Targeting Mitochondrial Fission as a Potential Therapeutic for Abdominal Aortic Aneurysm. , 2020, Cardiovascular research.
[3] Shanshan Liu,et al. HuR (Human Antigen R) Regulates the Contraction of Vascular Smooth Muscle and Maintains Blood Pressure , 2020, Arteriosclerosis, thrombosis, and vascular biology.
[4] K. Rottner,et al. Actin dynamics in cell migration , 2019, Essays in biochemistry.
[5] K. Moore,et al. Regulation of Stress Granule Formation by Inflammation, Vascular Injury, and Atherosclerosis. , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[6] M. Ray,et al. RNA stability protein ILF3 mediates cytokine‐induced angiogenesis , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] Michael J. Sweredoski,et al. FXR1 Is an IL-19-Responsive RNA-Binding Protein that Destabilizes Pro-inflammatory Transcripts in Vascular Smooth Muscle Cells. , 2018, Cell reports.
[8] S. Gunst,et al. Rho kinase collaborates with p21‐activated kinase to regulate actin polymerization and contraction in airway smooth muscle , 2018, The Journal of physiology.
[9] Laurel A. Grisanti,et al. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in Il19−/−×Ldlr−/− Double Knockout Mice by Dysregulation of mRNA Stability Protein HuR (Human Antigen R) , 2018, Arteriosclerosis, thrombosis, and vascular biology.
[10] W. Ge,et al. The tandem Agenet domain of fragile X mental retardation protein interacts with FUS , 2017, Scientific Reports.
[11] S. Eguchi,et al. Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC. , 2017, Journal of molecular and cellular cardiology.
[12] K. Moore,et al. IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages. , 2016, The American journal of pathology.
[13] A. Duggirala,et al. cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1 , 2015, Journal of molecular and cellular cardiology.
[14] B. Bardoni,et al. CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome , 2014, Front. Cell. Neurosci..
[15] M. Kessels,et al. FMRP regulates actin filament organization via the armadillo protein p0071 , 2013, RNA.
[16] Peter J Hume,et al. Arf6 coordinates actin assembly through the WAVE complex, a mechanism usurped by Salmonella to invade host cells , 2013, Proceedings of the National Academy of Sciences.
[17] Linnaea E. Ostroff,et al. CYFIP1 Coordinates mRNA Translation and Cytoskeleton Remodeling to Ensure Proper Dendritic Spine Formation , 2013, Neuron.
[18] M. Goumans,et al. Quaking, an RNA-Binding Protein, Is a Critical Regulator of Vascular Smooth Muscle Cell Phenotype , 2013, Circulation research.
[19] Amber L. Couzens,et al. The CRAPome: a Contaminant Repository for Affinity Purification Mass Spectrometry Data , 2013, Nature Methods.
[20] S. Gunst,et al. The Small GTPase RhoA Regulates the Contraction of Smooth Muscle Tissues by Catalyzing the Assembly of Cytoskeletal Signaling Complexes at Membrane Adhesion Sites* , 2012, The Journal of Biological Chemistry.
[21] L. Maquat,et al. Regulation of cytoplasmic mRNA decay , 2012, Nature Reviews Genetics.
[22] Michael J. Sweredoski,et al. Protein Interaction Profiling of the p97 Adaptor UBXD1 Points to a Role for the Complex in Modulating ERGIC-53 Trafficking* , 2012, Molecular & Cellular Proteomics.
[23] S. Ceman,et al. Fragile X family members have important and non-overlapping functions , 2011, Biomolecular concepts.
[24] O. Jensen,et al. WAVE regulatory complex activation by cooperating GTPases Arf and Rac1 , 2011, Proceedings of the National Academy of Sciences.
[25] D. Licatalosi,et al. FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.
[26] M. Mann,et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.
[27] Surbhi Jain,et al. The Anti‐Inflammatory Cytokine Interleukin‐19 Inhibits Smooth Muscle Cell Migration and Activation of Cytoskeletal Regulators of VSMC Motility , 2011, American journal of physiology. Cell physiology.
[28] Zbyszek Otwinowski,et al. Structure and Control of the Actin Regulatory WAVE Complex , 2010, Nature.
[29] P. Pacaud,et al. The role of Rho protein signaling in hypertension , 2010, Nature Reviews Cardiology.
[30] M. Autieri,et al. Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability. , 2010, Journal of molecular and cellular cardiology.
[31] K. Khalili,et al. RNA-binding protein HuR regulates RGS4 mRNA stability in rabbit colonic smooth muscle cells. , 2010, American journal of physiology. Cell physiology.
[32] J. W. Rush,et al. RhoA-Rho kinase signaling mediates endothelium- and endoperoxide-dependent contractile activities characteristic of hypertensive vascular dysfunction. , 2010, American journal of physiology. Heart and circulatory physiology.
[33] R. Torres,et al. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure , 2010, Nature Medicine.
[34] M. Mann,et al. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.
[35] S. Gunst,et al. Cytoskeletal remodeling in differentiated vascular smooth muscle is actin isoform dependent and stimulus dependent. , 2008, American journal of physiology. Cell physiology.
[36] S. Gunst,et al. Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction. , 2008, American journal of physiology. Cell physiology.
[37] D. Tang,et al. Physiologic Properties and Regulation of the Actin Cytoskeleton in Vascular Smooth Muscle , 2008, Journal of cardiovascular pharmacology and therapeutics.
[38] É. Khandjian,et al. Fragile X related protein 1 isoforms differentially modulate the affinity of fragile X mental retardation protein for G-quartet RNA structure , 2006, Nucleic acids research.
[39] Niels Volkmann,et al. Mechanism of Filament Nucleation and Branch Stability Revealed by the Structure of the Arp2/3 Complex at Actin Branch Junctions , 2005, PLoS biology.
[40] J. Mandel,et al. FMRP interferes with the Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts. , 2005, Human molecular genetics.
[41] É. Khandjian,et al. Fragile X-related Protein FXR1P Regulates Proinflammatory Cytokine Tumor Necrosis Factor Expression at the Post-transcriptional Level* , 2005, Journal of Biological Chemistry.
[42] D. Nelson,et al. Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo. , 2004, Human molecular genetics.
[43] D. Hartshorne,et al. Activation of RhoA and Inhibition of Myosin Phosphatase as Important Components in Hypertension in Vascular Smooth Muscle , 2003, Circulation research.
[44] Sebastian Maurer-Stroh,et al. The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. , 2003, Trends in biochemical sciences.
[45] J. Darnell,et al. Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.
[46] J. Mandel,et al. The Fragile X mental retardation protein , 2001, Brain Research Bulletin.
[47] J. Mandel,et al. A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[48] A. Takeshita,et al. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] T. Gibson,et al. Dissecting FMR1, the protein responsible for fragile X syndrome, in its structural and functional domains. , 1999, RNA.
[50] Alun D. Hughes,et al. Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle. , 1996, General pharmacology.
[51] A. Poustka,et al. Highly conserved 3' UTR and expression pattern of FXR1 points to a divergent gene regulation of FXR1 and FMR1. , 1995, Human molecular genetics.
[52] I. Zachary,et al. Signalling mechanisms in the regulation of vascular cell migration. , 1995, Cardiovascular research.
[53] J. Mandel,et al. A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. , 1995, Human molecular genetics.
[54] J. Mandel,et al. The FMR–1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation , 1993, Nature Genetics.
[55] OUP accepted manuscript , 2021, Nucleic Acids Research.
[56] D. Arveiler,et al. Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study , 2010, Journal of Human Hypertension.
[57] Stefan Offermanns,et al. G12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertension , 2008, Nature Medicine.
[58] P. Ngo,et al. Collagen gel contraction assay. , 2006, Methods in molecular biology.
[59] V. V. van Hinsbergh,et al. Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system. , 2001, Arteriosclerosis, thrombosis, and vascular biology.